Ccr5 and Cxcr2 promote pancreatic cancer progression30,31 and metastasis (in the case of Cxcr2), and their chemical inhibition has been proposed as cancer immunotherapy32,33. The gene discussed is CXCR2; the disease is familial pancreatic carcinoma.